Diabetes as an Accelerator of Cognitive Impairment and Alzheimer's Disease

NACompletedINTERVENTIONAL
Enrollment

54

Participants

Timeline

Start Date

July 1, 2019

Primary Completion Date

April 15, 2020

Study Completion Date

April 15, 2020

Conditions
Patients Aged 65-85 (Both Included)Diagnosed of Mild Cognitive ImpairmentDiagnosed of Type 2 Diabetes in Active Treatment (Hypoglycemic Agents) for a Period ≥5 Years
Interventions
DEVICE

Smart pillbox

The smart electronic pillbox will monitor adherence to pharmacological treatment by means of registering time of medications intake. It will incorporate visual and auditory reminders for taking medications (all of them, being or not being inside the dispenser such as insulin or eye drops). The dispenser will also have sensors and alarms to ensure the proper preservation of the medicines contained. The dispenser will be recharged weekly by a trained pharmacist. Each dispenser will be identified unequivocally with one user, and it will be interconnected with a mobile application (app).

OTHER

Interactive digital platform

The digital interactive platform will allow communication between patients and caregivers and healthcare professionals. Its aims are to provide feedback and guidelines on treatment adherence and also, on how to better optimize treatment on cardiovascular risk factors. The platform will inform about medication dosages and intake schedule, healthy lifestyles related to diabetes, occurrence of adverse events, and it will also monitor patients' glycemic control. In this sense, several alarms are programmed to warn caregivers or even healthcare professionals when the patient has hyperglycemia or hypoglycaemia. The platform will provide too guidelines on how to treat hypo or hyperglycemia as well as most common adverse events, and it will describe reasons to have suffered it.

Trial Locations (8)

08402

Fundació Privada Hospital Asil de Granollers (HAG), Granollers

08243

Fundació Althaia (FA), Manresa

08221

Fundació Recerca Mútua Terrassa (FMT), Terrassa

08227

Consorci Sanitari de Terrassa (CST), Terrassa

08500

Consorci Hospitalari de Vic (CHV), Vic

08023

Parc Sanitari Pere Virgili, Barcelona

08034

LambdaLoopers, Barcelona

08035

University Hospital Vall d'Hebron - Vall d'Hebron Institute of Research, Barcelona

Sponsors
All Listed Sponsors
collaborator

Hospital Vall d'Hebron

OTHER

collaborator

Consorci Sanitari de Terrassa

OTHER

collaborator

Fundació Recerca Mútua Terrassa (FMT)

UNKNOWN

collaborator

Clínica Universitària de la Fundació Universitària del Bages (FUB)

UNKNOWN

collaborator

Althaia Xarxa Assistencial Universitària de Manresa

OTHER

collaborator

Fundació Privada Hospital Asil de Granollers (HAG)

UNKNOWN

collaborator

Consorci Hospitalari de Vic

OTHER

collaborator

LambdaLoopers

OTHER

collaborator

Universitat Politècnica de Catalunya

OTHER

collaborator

Leitat

UNKNOWN

collaborator

Mixestat

UNKNOWN

collaborator

Meditecnologia

UNKNOWN

lead

Parc Sanitari Pere Virgili

OTHER

NCT03578991 - Diabetes as an Accelerator of Cognitive Impairment and Alzheimer's Disease | Biotech Hunter | Biotech Hunter